𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of the β4 integrin subunit is closely related to hematogenous metastasis in gastric cancer

✍ Scribed by Vielhaber, A.; Schneider, U.; Cao, Y.; Schlag, P.M.

Book ID
123601312
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
264 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Integrin expression in colon cancer cell
Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the β6 integrin subunit
✍ Jun Niu; Douglas J. Dorahy; Xinhua Gu; R.J. Scott; Brian Draganic; Nuzhat Ahmed; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 268 KB

## Abstract We have previously reported that the αvβ6 integrin upregulates its own expression in a protein kinase C‐dependent manner with increasing cell density. The wild‐type β6 integrin subunit has also been shown to promote tumour growth __in vivo__ and its growth‐enhancing effect is regulated

Loss of expression of the gene deleted i
Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma
✍ Makoto Saegusa; Miki Hashimura; Atsuko Hara; Isao Okayasu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

## Background: Although frequent loss of the tumor suppressor gene deleted in colon carcinoma (dcc) has been demonstrated in endometrial carcinoma, an alteration of the expression during normal menstrual cycle and tumorigenesis from hyperplastic lesions is still unclear. ## Methods: A total of 15

Blood group antigens and integrins as bi
Blood group antigens and integrins as biomarkers in head and neck cancer: Is aberrant tyrosine phosphorylation the cause of altered α6β4 integrin expression?
✍ Dr. Thomas E. Carey; Thankam S. Nair; Catherine Chern; Monica Liebert; H. Barton 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 878 KB

Head and neck cancer is a capricious disease that varies greatly in its clinical behavior. The development of biomarkers that can distinguish between biologically aggressive and indolent tumors has been a long term goal of our laboratories. Predictive markers applicable to biopsy specimens should fa